Advancements in immunology, surgical oncology, and digital health define recent developments in medical research and public health initiatives.

Autoimmune researchers are investigating the safety of CAR T-cell therapy following three patient deaths, leading to the indefinite suspension of several clinical trials.

New research indicates that retinal neurodegeneration can occur even with A1c levels that fall below the current clinical threshold for diagnosing prediabetes.

The monoclonal antibody daxdilimab has demonstrated a favorable safety profile and significant efficacy in reducing disease activity for patients with moderate-to-severe discoid lupus erythematosus.

A phase 3 trial shows that the IL-4 receptor inhibitor oturkibart provides long-term efficacy and safety for treating the chronic skin condition prurigo nodularis.

Implanting cesium-131 radiation tiles during brain metastasis surgery has been linked to improved surgical bed control and longer survival rates compared to standard postoperative radiation.

Healthcare cybersecurity experts are warning of increased risks following AI-driven cyberattacks, highlighting the need for stronger defenses against threats targeting government medical infrastructure.

England has expanded its public health program to provide free flu vaccinations to homeless individuals through mobile clinics that do not require proof of address.

A novel smartphone-based 3D tool has been developed to accurately measure eyelid ptosis, potentially simplifying the diagnostic process for clinicians determining the need for surgical intervention.